skip to main content

Clients with major transactions routinely face shareholder and other litigation seeking to block or enforce a deal. As experienced and business-savvy litigators, we are able to fend off many such cases, often breaking new legal ground in the process.


The American Lawyer Names Andrew Gordon and Jaren Janghorbani “Litigators of the Week” Runners-Up for Symbiont Trial Win

Litigation partners Andrew Gordon and Jaren Janghorbani were named “Litigators of the Week” runners-up by The American Lawyer for their trial win for Inc. in its lawsuit against Ipreo Holdings and IHS Markit Ltd.

The lawsuit arose out of the defendants’ bad-faith efforts to undermine Synaps Loans, a joint venture between Symbiont and Ipreo intended to leverage blockchain technology in the syndicated loan market. Symbiont challenged the 2018 acquisition of Ipreo by IHS Markit—Synaps’ main competitor—as a violation of the broad non-compete provision contained in Synaps’ joint venture agreement.

Following a four-day trial held remotely in December 2020, Vice Chancellor J. Travis Laster of the Delaware Court of Chancery sided with Symbiont on substantially all issues and awarded $142 million in damages to the joint venture, which Symbiont half-owns.

The article also highlights other members of the Paul, Weiss team, including litigation counsel Daniel Mason and associates Maia Usui and Katarina Broeksmit.

» more information

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy